1180 views | 1 decade ago
Trying to determine the health of an embryo by conventional microscopic methods has its limitations. With next-generation sequencing technologies and Preimplantation Genetic Screening (PGS) from Illumina,...
476 views | 1 decade ago
High-throughput, next-generation sequencing for Preimplantation Genetic Screening (PGS) to detect aneuploid embryos is a game changer for IVF clinics and labs. Clinics are increasingly turning to PGS...
245 views | 1 decade ago
Traditional genetic embryo screening methods have been limited by less accurate, non-quantitative lab analysis. IVF success rates have been low as a result of the higher risk of miscarriage and genetic...
420 views | 1 decade ago
Genetic embryo screening methods have come a long way. Next-generation sequencing has led to advancements in PGS and what we can determine about the chromosomal health of embryos. Illumina technology...
456 views | 1 decade ago
Alan Handyside, Head of PGD at Illumina talks about the first published randomised prospective IVF study of preimplantation chromosome analysis using 24sure demonstrates that selectively implanting...
3610 views | 1 decade ago
The film explains what it means to be a balanced translocation carrier and the problems with fertility that may be experienced. IVF with translocation preimplantation genetic diagnosis (translocation...
57 views | 6 years ago
さまざまな種類の白血病やリンパ腫の5,000名の患者を全ゲノムシーケンスし、最終的に疾患の基礎を理解するという目標について、ミュンヘン白血病研究所（MLL）のTorsten Haferlach博士が説明します。研究チームがNovaSeq™ 6000 システムのフローセルと拡張性を活用してこれまで以上に研究を拡大させている様子をご覧ください。 イルミナ株式会社 jp.illumina.com